Developer docs
API playgroundTry for free, no card

Search company profiles

Numan

Full company profile

uuid000089f

Namestring
Numan
Legal namestring
Vir Health Limited
Websiteurl
numan.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Numan is a UK-based, CQC-regulated digital health platform (trading name of Vir Health Limited) that delivers direct-to-consumer clinical services across four integrated verticals: weight loss (anchored by injectable and oral GLP-1 medications including Mounjaro, Wegovy, Wegovy Pill and OTC Alli, plus health coaching), men's health (testosterone replacement therapy, erectile dysfunction, premature ejaculation and hair loss), women's health (menopause, perimenopause, female hormone testing and supplements), and at-home diagnostics (a broad capillary and venous blood-test portfolio with clinician-prepared reports). The platform combines online health questionnaires, AI-assisted triage (the 'Nubot' chatbot and a weight-loss coaching chatbot), in-house clinical review by GMC/GPhC/NMC-registered clinicians, dispensing by its GPhC-licensed pharmacy (Numan Operations Limited), and free discreet doorstep delivery to UK addresses, all managed through a consumer subscription account and a native iOS/Android app.

Under the hood, Numan's technology stack is a vertically integrated SaaS-style clinical workflow with proprietary AI components: a generative AI Health Assistant launched in 2025, computer-vision weight verification for safe prescribing of weight-loss medication, an AI-driven health-coaching layer supported by a dedicated Head of AI Coaching and Behavioural Science, and integrations with identity-verification providers (W2 Global, LexisNexis), NHS Summary Care Record processors (The Independent Pharmacy, Health Finder Pro), wearables data (Apple Watch, Strava) and Intercom for customer care. The CQC registration, GPhC-licensed pharmacy and UKAS-accredited partner labs together create a regulated infrastructure that newer digital health entrants must replicate before competing at scale.

Commercially, Numan runs a D2C subscription model with three subscription structures (rolling 28-day, prepaid 3-/6-month, and 3-/6-/12-month Commitment Packages with 8–12% RRP discounts), supplemented by one-off product purchases, at-home blood tests and pay-as-you-go doctor consultations. Revenue is concentrated in the UK, scaled to $90M in 2024 (more than doubled year-on-year) on a 650,000+ patient base across obesity management, men's health and diagnostics, with profitability first achieved approximately 18 months before the July 2025 €51.6M Series B extension that funds international expansion, women's health and AI development.

Short descriptiontext

Numan is a UK-based, CQC-regulated digital health platform offering subscription-based direct-to-consumer care across weight loss, men's health, women's health and at-home diagnostics, supported by an in-house clinical team, a GPhC-licensed pharmacy and an AI-augmented mobile app.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
digital health platform, weight loss treatment, men's health services, telehealth consultations, at-home diagnostics
Industry2 codes
PRIMARYHLAIADAK
Men’s Health (OTC Urologic & Sexual Health)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
Product category
Digital Health Platform
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model6 records
1Prescription & treatment subscriptions
TypeSubscription Recurring
Description

Recurring monthly subscriptions for prescription treatments (weight loss, ED, hair loss, testosterone, menopause). Three subscription structures: Rolling 1-month subscription on a 28-day cycle; Prepaid 3- or 6-month packages with upfront payment at a discounted rate; Commitment Packages (3, 6 or 12 months paid monthly) carrying 8%/10%/12% off RRP respectively, with a 12-month prescription term.

numan.com
2One-off product & non-prescription purchases
TypeTransaction Fee
Description

One-time purchases of non-prescription medicines, supplements and standalone products (e.g., Alli, weight-loss supplements, hair-loss kits). Customers may also complete one-off doctor's consultations booked and paid for individually.

numan.com
3Diagnostics / blood-test sales
TypeTransaction Fee
Description

Sales of at-home capillary blood tests (Complete, Core, Male/Female Hormone, Menopause, Perimenopause, Testosterone, ED, Weight Loss, Cardiovascular, Cholesterol, Metabolic, Nutritional, Thyroid, Sexual Performance). Includes optional follow-up clinician consultations and the 'Test is free if we don't find anything' promotion.

numan.com
4Repeat prescriptions
TypeSubscription Recurring
Description

Repeat dispensing of approved prescriptions up to the clinician-defined allowance, automatically recurring and charged 48 hours before dispatch; patients can pause or cancel via their account.

numan.com
5Doctor & phone-clinic consultations
TypeProfessional Services
Description

Fee-based one-off doctor consultations and phone-clinic consultations, with refunds if cancelled at least 24 hours in advance or if the clinician cancels.

numan.com
6Supplements & ancillary products
TypeTransaction Fee
Description

Sale of branded supplements (Omega 3 Boost, Sleep Deep, Vitamin D3 with K2, Hair Support, High Strength Testosterone Supplement, Maca Root, Prostate Pro, Weight Loss Support, multivitamins, Fit & Fuel shakes, etc.) sold alongside core treatments.

numan.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Pricing details7 tiers
1Weight Loss Rolling Subscription (1-month)
ModelSubscriptionBilling cadenceMonthly
Notes

Billed monthly in advance on a 28-day cycle; no commitment or auto-renewal once the 12-month prescription term ends.

numan.com
2Weight Loss Prepaid 3- or 6-Month Package
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Prepay upfront for 3 or 6 months at a preferential discounted rate; dose is fixed for the package term; pro-rata refund for undelivered medication if cancelled.

numan.com
3Weight Loss Commitment Packages (3, 6 or 12 months, paid monthly)
ModelSubscriptionBilling cadenceMonthly
Notes

3-month commitment: 8% off RRP; 6-month commitment: 10% off RRP; 12-month commitment: 12% off RRP. Cannot be paused or cancelled during the commitment term except for medical grounds or other exemptions.

numan.com
4Non-prescription products, supplements & one-off purchases
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

One-off purchase with 14-day change-of-mind right (excludes sealed/hygiene items); refunds for damaged/defective/wrong items within 2 months.

numan.com
5Blood tests / diagnostics
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual at-home blood tests charged per unit; 'Test is free if we don't find anything' full-refund within 90 days on Complete Blood Test; £10 back on first capillary blood test returned within 10 days; free replacement if first sample untestable.

numan.com
6One-off Doctor / phone clinic consultation
ModelOtherBilling cadencePay-as-you-go
Notes

Fee-based single consultation; full refund if cancelled at least 24 hours before start or if clinician cancels.

numan.com
7Hair-loss Money-Back Guarantee
ModelOtherBilling cadencePay-as-you-go
Notes

First-time users starting after 1 April 2022 who comply with photo-documentation and treatment guidelines may claim a refund between 180 and 210 days after clinician acceptance if not satisfied.

numan.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Numan is a UK digital health platform that sells subscription-based prescription treatments, clinician consultations, at-home blood diagnostics, health coaching and supplements across four verticals: weight loss (Mounjaro, Wegovy, Wegovy Pill, Alli), men's health (testosterone, ED, PE, hair loss), women's health (menopause/perimenopause) and general diagnostics. Customers complete an online health questionnaire, are reviewed by Numan's in-house CQC-regulated clinicians, receive medication from Numan's GPhC-licensed in-house pharmacy and get it delivered discreetly to UK addresses, with ongoing management via the Numan app.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 2024 revenue of $90 million (more than doubled year-on-year)
+5 more records
Product overview1 text field

Numan is a UK-based digital health platform offering a unified subscription-style service combining online consultations, prescription medications, at-home diagnostics, health coaching, supplements and an AI-augmented mobile app — delivered as a single integrated platform across four verticals: Weight Loss, Men's Health (testosterone/ED/PE/hair loss), Women's Health (menopause/perimenopause), and Diagnostics. At the platform level, the Numan website and the Numan Digital Healthcare App tie these verticals together, providing one customer account, one electronic patient record and shared clinical infrastructure (clinician consultations, partner pharmacies, UKAS-accredited partner labs, and identity-verification partners W2 Global and LexisNexis). On top of the platform sit AI capabilities including Nubot (interactive customer-service chatbot), an AI chatbot for weight-loss health coaching, AI image verification for weight, and the new Numan AI Health Assistant. The product portfolio specifically includes the Numan Weight Loss Programme (with medications Mounjaro, Wegovy, Wegovy Pill, Alli) and Health Coaching; Men's Health services for Low Testosterone (TRT), Erectile Dysfunction (Sildenafil, Tadalafil, Tadalafil Daily, Viagra Connect), Premature Ejaculation (Dapoxetine, Paroxetine, Delay Spray, Delay Wipes), and Hair Loss (Finasteride, medicated sprays/foams, kits, supplements); Women's Health menopause and perimenopause services (including Perimenopause Supplement Kit and blood tests); a broad Diagnostics range (Complete, Core, Male Hormone, Female Hormone, Menopause/Perimenopause, Testosterone Venous, Weight Loss, Cardiovascular, Cholesterol, Thyroid, Nutritional, Metabolic, Sexual Performance blood tests); a Supplements catalogue; and a One-Off Doctor's Consultation service — all delivered through a CQC-regulated and GPhC-licensed pharmacy infrastructure.

Product and service2 records
1Weight Loss Programme
CategoryWeight Loss Programme
Description

Long-term weight-loss programme combining prescription medication (Mounjaro, Wegovy, Wegovy Pill, Alli), clinician support and one-to-one health coaching for UK adults seeking clinically supervised obesity management. Patients on the full programme including coaching lose 29% more weight in the first 6 months.

2Mounjaro (tirzepatide) Weight Loss Treatment
Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeTechnology or Integration
Description

Identity verification partner used by Numan to verify patients ordering prescription-only medicines. Numan shares first name, last name, date of birth and address with W2 Global, which matches the data against public databases.

Strategic tierCoreTypeTechnology or Integration
Description

Second identity verification partner used by Numan for prescription-only medicines, validating patient data against public records and reference databases.

Strategic tierCoreTypeTechnology or Integration
Description

Clinical partner acting as Numan's processor to carry out NHS Summary Care Record (SCR) look-ups on Numan's behalf, helping verify current medicines, allergies and previous reactions to support safe prescribing.

Strategic tierCoreTypeTechnology or Integration
Description

Second clinical partner acting as Numan's processor for NHS Summary Care Record (SCR) look-ups, supporting safe prescribing of Numan's prescription medications.

5Intercom
Strategic tierCoreTypeTechnology or Integration
Description

Third-party host of Numan's Customer Care team conversations (name, email, conversation content), hosted in the United States and certified under the UK-US Data Privacy Framework.

numan.com
Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

Apple App Store distribution partner for the Numan Digital Healthcare app (App ID 1624465181) and integration with Apple Watch wearables data shared by consenting users.

Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

Google Play Store distribution partner for the Numan Digital Healthcare Android app (com.numan.healthcare).

Strategic tierCoreTypeOthers
Description

UK regulator registering and inspecting Numan (registration 1-6118870417); sets the standards (Health and Social Care Act 2008, safe prescribing) Numan must meet to operate its clinical service.

Strategic tierCoreTypeOthers
Description

UK regulator licensing Numan Operations Limited as a registered pharmacy (registration 9011408) and Superintendent Pharmacist Sarah Morgan (GPhC 2049981); sets the standards for pharmacy and dispensing practice.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-listed D2C telehealth platform selling prescription treatments for hair loss, ED, weight loss and mental health alongside supplements — same vertically integrated online clinic + subscription model that Numan runs in the UK. Closest global comparable by business model, customer mix and category footprint.

TypeDirect peer
Description

UK and Europe-based online clinic offering ED, weight loss, hair loss and STI treatments via online consultation and home delivery. Direct UK competitor in the same sensitive-conditions subscription categories as Numan.

TypeDirect peer
Description

UK men's health D2C platform offering ED, hair loss, TRT and weight-management treatments via online consultation and subscription. Direct UK competitor in Numan's heritage men's-health vertical.

TypeDirect peer
Description

UK online clinic offering prescription ED, weight loss, hair loss and STI treatments with home delivery. Direct UK competitor in the same D2C prescription categories as Numan.

5Ro
TypeDirect peer
Description

US D2C telehealth and pharmacy platform (Roman was its men's-health brand) covering ED, hair loss, weight loss and diagnostics with vertically integrated pharmacy. Closely comparable vertically integrated online clinic model to Numan.

TypeDirect peer
Description

US D2C telehealth subscription service focused specifically on ED treatment via online consultation and home delivery. Comparable to Numan's ED vertical on subscription mechanics and direct-to-patient online prescribing model.

7Boots Online Doctor
TypeBroad incumbent
Description

UK pharmacy incumbent Boots' online doctor service offering prescription treatments (ED, hair loss, weight loss, contraception, etc.) with in-store and home delivery. Larger incumbent covering overlapping categories but as part of a wider pharmacy and retail portfolio.

8eMed (formerly Babylon Health UK)
TypeBroad incumbent
Description

UK digital health incumbent providing online consultations and clinician-led care across multiple conditions. Broader portfolio player rather than a sensitive-conditions specialist, but operates in the same UK CQC-regulated digital health space.

TypeEmerging player
Description

Global D2C women's and family health telehealth platform covering fertility, maternity, menopause and paediatric care. Comparable to Numan's newly launched women's health vertical (menopause/perimenopause) by category and digitally enabled care model.

TypeRegional player
Description

Munich-headquartered D2C telehealth group operating online clinics across Europe for sensitive conditions (weight loss, ED, hair loss, mental health). Comparable business model to Numan, but operating in different European geographies rather than directly competing in the UK.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration9 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Numan

Digital Health Platformnuman.com

Numan is a UK-based, CQC-regulated digital health platform offering subscription-based direct-to-consumer care across weight loss, men's health, women's health and at-home diagnostics, supported by an in-house clinical team, a GPhC-licensed pharmacy and an AI-augmented mobile app.

What Numan does

Numan is a UK-based, CQC-regulated digital health platform (trading name of Vir Health Limited) that delivers direct-to-consumer clinical services across four integrated verticals: weight loss (anchored by injectable and oral GLP-1 medications including Mounjaro, Wegovy, Wegovy Pill and OTC Alli, plus health coaching), men's health (testosterone replacement therapy, erectile dysfunction, premature ejaculation and hair loss), women's health (menopause, perimenopause, female hormone testing and supplements), and at-home diagnostics (a broad capillary and venous blood-test portfolio with clinician-prepared reports). The platform combines online health questionnaires, AI-assisted triage (the 'Nubot' chatbot and a weight-loss coaching chatbot), in-house clinical review by GMC/GPhC/NMC-registered clinicians, dispensing by its GPhC-licensed pharmacy (Numan Operations Limited), and free discreet doorstep delivery to UK addresses, all managed through a consumer subscription account and a native iOS/Android app.

Under the hood, Numan's technology stack is a vertically integrated SaaS-style clinical workflow with proprietary AI components: a generative AI Health Assistant launched in 2025, computer-vision weight verification for safe prescribing of weight-loss medication, an AI-driven health-coaching layer supported by a dedicated Head of AI Coaching and Behavioural Science, and integrations with identity-verification providers (W2 Global, LexisNexis), NHS Summary Care Record processors (The Independent Pharmacy, Health Finder Pro), wearables data (Apple Watch, Strava) and Intercom for customer care. The CQC registration, GPhC-licensed pharmacy and UKAS-accredited partner labs together create a regulated infrastructure that newer digital health entrants must replicate before competing at scale.

Commercially, Numan runs a D2C subscription model with three subscription structures (rolling 28-day, prepaid 3-/6-month, and 3-/6-/12-month Commitment Packages with 8–12% RRP discounts), supplemented by one-off product purchases, at-home blood tests and pay-as-you-go doctor consultations. Revenue is concentrated in the UK, scaled to $90M in 2024 (more than doubled year-on-year) on a 650,000+ patient base across obesity management, men's health and diagnostics, with profitability first achieved approximately 18 months before the July 2025 €51.6M Series B extension that funds international expansion, women's health and AI development.

Numan firmographics

Firmographics
Name
Numan
Legal name
Vir Health Limited
Website
https://numan.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
251–500 employees
Short description
Numan is a UK-based, CQC-regulated digital health platform offering subscription-based direct-to-consumer care across weight loss, men's health, women's health and at-home diagnostics, supported by an in-house clinical team, a GPhC-licensed pharmacy and an AI-augmented mobile app.
Ownership category
akta.pro rank

Numan industry classification

Industry
Product category
Digital Health Platform
akta.pro industry
PRIMARYHLAIADAK
Men’s Health (OTC Urologic & Sexual Health)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAHAOAK
Home-Use & OTC Rapid Self-Tests (Consumer POCT kits)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics

Keywords

  • Digital health platform
  • Weight loss treatment
  • Men's health services
  • Telehealth consultations
  • At-home diagnostics

Where Numan is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Numan business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Prescription & treatment subscriptions: Recurring monthly subscriptions for prescription treatments (weight loss, ED, hair loss, testosterone, menopause). Three subscription structures: Rolling 1-month subscription on a 28-day cycle; Prepaid 3- or 6-month packages with upfront payment at a discounted rate; Commitment Packages (3, 6 or 12 months paid monthly) carrying 8%/10%/12% off RRP respectively, with a 12-month prescription term.
  2. One-off product & non-prescription purchases: One-time purchases of non-prescription medicines, supplements and standalone products (e.g., Alli, weight-loss supplements, hair-loss kits). Customers may also complete one-off doctor's consultations booked and paid for individually.
  3. Diagnostics / blood-test sales: Sales of at-home capillary blood tests (Complete, Core, Male/Female Hormone, Menopause, Perimenopause, Testosterone, ED, Weight Loss, Cardiovascular, Cholesterol, Metabolic, Nutritional, Thyroid, Sexual Performance). Includes optional follow-up clinician consultations and the 'Test is free if we don't find anything' promotion.
  4. Repeat prescriptions: Repeat dispensing of approved prescriptions up to the clinician-defined allowance, automatically recurring and charged 48 hours before dispatch; patients can pause or cancel via their account.
  5. Doctor & phone-clinic consultations: Fee-based one-off doctor consultations and phone-clinic consultations, with refunds if cancelled at least 24 hours in advance or if the clinician cancels.
  6. Supplements & ancillary products: Sale of branded supplements (Omega 3 Boost, Sleep Deep, Vitamin D3 with K2, Hair Support, High Strength Testosterone Supplement, Maca Root, Prostate Pro, Weight Loss Support, multivitamins, Fit & Fuel shakes, etc.) sold alongside core treatments.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyWeight Loss Rolling Subscription (1-month)
SubscriptionMulti-year contractWeight Loss Prepaid 3- or 6-Month Package
SubscriptionMonthlyWeight Loss Commitment Packages (3, 6 or 12 months, paid monthly)
One time/ perpetual licensePay-as-you-goNon-prescription products, supplements & one-off purchases
Unit PricingPay-as-you-goBlood tests / diagnostics
OtherPay-as-you-goOne-off Doctor / phone clinic consultation
OtherPay-as-you-goHair-loss Money-Back Guarantee

Go-to-market motion3 records

Distribution channels3 records

Marketing channels10 records

Numan product offering

Product offering

Core offering

Numan is a UK digital health platform that sells subscription-based prescription treatments, clinician consultations, at-home blood diagnostics, health coaching and supplements across four verticals: weight loss (Mounjaro, Wegovy, Wegovy Pill, Alli), men's health (testosterone, ED, PE, hair loss), women's health (menopause/perimenopause) and general diagnostics. Customers complete an online health questionnaire, are reviewed by Numan's in-house CQC-regulated clinicians, receive medication from Numan's GPhC-licensed in-house pharmacy and get it delivered discreetly to UK addresses, with ongoing management via the Numan app.

Product overview

Numan is a UK-based digital health platform offering a unified subscription-style service combining online consultations, prescription medications, at-home diagnostics, health coaching, supplements and an AI-augmented mobile app — delivered as a single integrated platform across four verticals: Weight Loss, Men's Health (testosterone/ED/PE/hair loss), Women's Health (menopause/perimenopause), and Diagnostics. At the platform level, the Numan website and the Numan Digital Healthcare App tie these verticals together, providing one customer account, one electronic patient record and shared clinical infrastructure (clinician consultations, partner pharmacies, UKAS-accredited partner labs, and identity-verification partners W2 Global and LexisNexis). On top of the platform sit AI capabilities including Nubot (interactive customer-service chatbot), an AI chatbot for weight-loss health coaching, AI image verification for weight, and the new Numan AI Health Assistant. The product portfolio specifically includes the Numan Weight Loss Programme (with medications Mounjaro, Wegovy, Wegovy Pill, Alli) and Health Coaching; Men's Health services for Low Testosterone (TRT), Erectile Dysfunction (Sildenafil, Tadalafil, Tadalafil Daily, Viagra Connect), Premature Ejaculation (Dapoxetine, Paroxetine, Delay Spray, Delay Wipes), and Hair Loss (Finasteride, medicated sprays/foams, kits, supplements); Women's Health menopause and perimenopause services (including Perimenopause Supplement Kit and blood tests); a broad Diagnostics range (Complete, Core, Male Hormone, Female Hormone, Menopause/Perimenopause, Testosterone Venous, Weight Loss, Cardiovascular, Cholesterol, Thyroid, Nutritional, Metabolic, Sexual Performance blood tests); a Supplements catalogue; and a One-Off Doctor's Consultation service — all delivered through a CQC-regulated and GPhC-licensed pharmacy infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

  • Weight Loss Programme Long-term weight-loss programme combining prescription medication (Mounjaro, Wegovy, Wegovy Pill, Alli), clinician support and one-to-one health coaching for UK adults seeking clinically supervised obesity management. Patients on the full programme including coaching lose 29% more weight in the first 6 months.
  • Mounjaro (tirzepatide) Weight Loss Treatment

Quantifiable outcome

  • 2024 revenue of $90 million (more than doubled year-on-year)
  • +5 more outcomes

Companies that use Numan

Customer profile

Segments6 records

Ideal customer profiles4 records

Numan technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration9 records

AI capability9 records

Feature5 records

Numan partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • W2 GlobalcoreTechnology or IntegrationIdentity verification partner used by Numan to verify patients ordering prescription-only medicines. Numan shares first name, last name, date of birth and address with W2 Global, which matches the data against public databases.
  • LexisNexiscoreTechnology or IntegrationSecond identity verification partner used by Numan for prescription-only medicines, validating patient data against public records and reference databases.
  • The Independent Pharmacy (ABSM Healthcare Ltd)coreTechnology or IntegrationClinical partner acting as Numan's processor to carry out NHS Summary Care Record (SCR) look-ups on Numan's behalf, helping verify current medicines, allergies and previous reactions to support safe prescribing.
  • Health Finder ProcoreTechnology or IntegrationSecond clinical partner acting as Numan's processor for NHS Summary Care Record (SCR) look-ups, supporting safe prescribing of Numan's prescription medications.
  • IntercomcoreTechnology or IntegrationThird-party host of Numan's Customer Care team conversations (name, email, conversation content), hosted in the United States and certified under the UK-US Data Privacy Framework.
  • AppleminorOEM/ Whitelabel/ Licensing PartnerApple App Store distribution partner for the Numan Digital Healthcare app (App ID 1624465181) and integration with Apple Watch wearables data shared by consenting users.
  • GoogleminorOEM/ Whitelabel/ Licensing PartnerGoogle Play Store distribution partner for the Numan Digital Healthcare Android app (com.numan.healthcare).
  • Care Quality Commission (CQC)coreOthersUK regulator registering and inspecting Numan (registration 1-6118870417); sets the standards (Health and Social Care Act 2008, safe prescribing) Numan must meet to operate its clinical service.
  • General Pharmaceutical Council (GPhC)coreOthersUK regulator licensing Numan Operations Limited as a registered pharmacy (registration 9011408) and Superintendent Pharmacist Sarah Morgan (GPhC 2049981); sets the standards for pharmacy and dispensing practice.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

Numan competitors and assessment

Company assessment

Direct peers

  • Hims & Hers Health: US-listed D2C telehealth platform selling prescription treatments for hair loss, ED, weight loss and mental health alongside supplements — same vertically integrated online clinic + subscription model that Numan runs in the UK. Closest global comparable by business model, customer mix and category footprint.
  • Zava: UK and Europe-based online clinic offering ED, weight loss, hair loss and STI treatments via online consultation and home delivery. Direct UK competitor in the same sensitive-conditions subscription categories as Numan.
  • Manual: UK men's health D2C platform offering ED, hair loss, TRT and weight-management treatments via online consultation and subscription. Direct UK competitor in Numan's heritage men's-health vertical.
  • MedExpress: UK online clinic offering prescription ED, weight loss, hair loss and STI treatments with home delivery. Direct UK competitor in the same D2C prescription categories as Numan.
  • Ro: US D2C telehealth and pharmacy platform (Roman was its men's-health brand) covering ED, hair loss, weight loss and diagnostics with vertically integrated pharmacy. Closely comparable vertically integrated online clinic model to Numan.
  • BlueChew: US D2C telehealth subscription service focused specifically on ED treatment via online consultation and home delivery. Comparable to Numan's ED vertical on subscription mechanics and direct-to-patient online prescribing model.

Broad incumbents

  • Boots Online Doctor: UK pharmacy incumbent Boots' online doctor service offering prescription treatments (ED, hair loss, weight loss, contraception, etc.) with in-store and home delivery. Larger incumbent covering overlapping categories but as part of a wider pharmacy and retail portfolio.
  • eMed (formerly Babylon Health UK): UK digital health incumbent providing online consultations and clinician-led care across multiple conditions. Broader portfolio player rather than a sensitive-conditions specialist, but operates in the same UK CQC-regulated digital health space.

Emerging players

  • Maven Clinic: Global D2C women's and family health telehealth platform covering fertility, maternity, menopause and paediatric care. Comparable to Numan's newly launched women's health vertical (menopause/perimenopause) by category and digitally enabled care model.

Regional players

  • Wellster Healthtech: Munich-headquartered D2C telehealth group operating online clinics across Europe for sensitive conditions (weight loss, ED, hair loss, mental health). Comparable business model to Numan, but operating in different European geographies rather than directly competing in the UK.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Numan social profiles

Digital presence

Numan compliance and trust

Trust signal

Compliance6 records

Numan financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Numan leadership team

Management profile

Number of profiles

Profiles5 records

Numan subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Numan funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Numan M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Numan

What does Numan do?

Numan is a UK digital health platform that sells subscription-based prescription treatments, clinician consultations, at-home blood diagnostics, health coaching and supplements across four verticals: weight loss (Mounjaro, Wegovy, Wegovy Pill, Alli), men's health (testosterone, ED, PE, hair loss), women's health (menopause/perimenopause) and general diagnostics. Customers complete an online health questionnaire, are reviewed by Numan's in-house CQC-regulated clinicians, receive medication from Numan's GPhC-licensed in-house pharmacy and get it delivered discreetly to UK addresses, with ongoing management via the Numan app.

Is Numan a public or private company?

Numan is a private company. It is classified as venture growth investor backed and is currently operating.

When was Numan founded?

Numan was founded in 2018. It employs 251 to 500 people.

Where is Numan based?

Numan is headquartered in London, United Kingdom, in the Europe region.

How does Numan make money?

Six revenue lines are on record. Prescription & treatment subscriptions are the primary driver. The others are one-off product & non-prescription purchases, diagnostics / blood-test sales, repeat prescriptions, doctor & phone-clinic consultations and supplements & ancillary products.

Who are Numan's main competitors?

Direct peers on record are Hims & Hers Health, Zava, Manual, MedExpress, Ro and BlueChew. Broad incumbents are Boots Online Doctor and eMed (formerly Babylon Health UK). Maven Clinic is listed as an emerging player. Wellster Healthtech is listed as a regional player.

Does Numan have an API?

No public API is recorded for Numan.

What industry is Numan in?

Numan's product category is Digital Health Platform. Its primary akta.pro industry code is HLAIADAK, Men’s Health (OTC Urologic & Sexual Health), with a secondary code of HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HealthpolicypartnershipNew white paper calls for urgent action to reverse UK obesity epidemicHPP and Numan launched a white paper at the Labour Party Conference calling for coordinated policy actions to reverse rising obesity rates in the UK. The document highlights that obesity costs the UK economy an estimated £126 billion annually and recommends measures such as recognizing obesity as a disease and scaling public-private partnerships.SilverwoodpartnersHealthcare Private Placement and M&A Transactions Review Week Ending July 20, 2025Sanofi acquired Blueprint Medicines for $9.5 billion, while 23andMe was acquired by the TTAM Research Institute for $305 million during the week ending July 20, 2025. Additionally, multiple healthcare startups including OpenEvidence and Numan secured significant venture funding rounds ranging from $6.8 million to $210 million.BebeezHealth startup Numan raises $57m as demand for weight loss drugs booms – BeBeez InternationalNuman raised $57m in equity and debt to scale internationally, with revenue doubling to $90m in 2024. The startup, which treats over 650,000 patients, predicts nearly $200m in 2025 revenue and plans to expand into female health and AI health coaching.Med-Tech InsightsDigital health provider Numan raises $60m fundingUK digital health provider Numan raised $60 million in fresh funding, consisting of a $30 million equity investment led by Big Pi Ventures and $27 million in growth capital from HSBC Innovation Banking. The company reported that its revenue more than doubled year-on-year to reach $90 million by the end of 2024, having achieved profitability 18 months ago. This capital will be used to scale infrastructure, expand into female health, enhance AI-driven capabilities, and pursue international growth.EU-StartupsLondon-based Numan raises €51.6 million for the next era of preventative, digital healthcareNuman raised €51.6 million in a Series B extension led by Big Pi Ventures, with €23.2 million in growth capital from HSBC Innovation Banking. The funding will expand into female health and scale infrastructure. Numan reported €77.4 million revenue in 2024 and targets 150% growth in 2025.BusinessCloudNuman raises £45m to expand into female healthNuman raised £45m in a Series B extension led by Big Pi Ventures, with Endeavor Catalyst and existing investors, plus £20m growth capital from HSBC. The firm reported revenue of £67m in 2024 and plans to expand into female health and scale AI-driven capabilities.BusinessCloudNuman raises £45m to expand into female healthNuman raised £45m in a Series B extension led by Big Pi Ventures, with Endeavor Catalyst and existing investors. The firm reported revenue more than doubling to £67m in 2024 and has treated over 650,000 patients. The funding will support expansion into female health and AI-driven capabilities.BusinessCloudNuman raises £45m to expand into female healthNuman raised £45m in a Series B extension led by Big Pi Ventures and Endeavor Catalyst, with HSBC Innovation Banking providing £20m growth capital. The firm reported revenue more than doubling to £67m in 2024 and has treated over 650,000 patients. The funding will support expansion into female health and AI-driven capabilities.BusinessCloudNuman raises £45m to expand into female healthDigital men's health platform Numan has raised £45m in a Series B round extension to fund its expansion into female health and scale operations. The company reported doubling its revenue to £67m in 2024 and achieving its first full year of profitability, supported by investors including Big Pi Ventures, Endeavor Catalyst, and HSBC Innovation Banking.Tech.euNuman secures $60M to scale preventive digital health platformUK healthtech company Numan has secured $60 million in Series B extension funding from investors including Big Pi Ventures and HSBC Innovation Banking, having achieved $90 million in 2024 revenue while serving over 650,000 patients across obesity management, men's health, and diagnostics. The funding will enable Numan to expand into female health and enhance preventive care offerings while scaling platform infrastructure and AI capabilities. The company, which first achieved profitability 18 months ago, projects 150% growth in 2025.